Clinical Trial Update: Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled trial comparing generic budesonide/formoterol to Symbicort in asthmatic participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol Fumarate Dihydrate (generic) (budesonide/formoterol fumarate dihydrate)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: Actavis Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2019-11-29